 |
 |
 |
 |
||||
 |
 |
 |
 |
 |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
|
|
Avera Pharmaceuticals
names Dinu Sen Chief Executive Officer, Former Senior Executive at Corus,
Cubist and Pathogenesis
SAN
DIEGO - September 14, 2006
Avera Pharmaceuticals, Inc., a privately held specialty pharmaceutical company developing neuroscience therapeutics, today announced the appointment of Dinu Sen as chief executive officer. He will replace Jeffrey F. McKelvy, founding president and CEO of Avera, who will transition to president and chief technical officer.
Mr. Sen joins Avera from Corus Pharma, Inc., where he had been chief commercial officer since 2004, and where his duties included oversight of manufacturing and inhalation technology, in addition to all commercial activities. During his 20 years of experience in the pharmaceutical industry, Dinu has played a key role in the launch or marketing of several of the most successful therapeutic products, including Epogen™, Neupogen™ and TOBI™.
Prior to joining Corus Pharma, Dinu was president and chief operating officer at Cubist Pharmaceuticals, where he was responsible for daily company operations. He also served as senior vice president of sales and marketing at PathoGenesis Corporation, and served in several senior marketing roles at Amgen, Inc. He has been instrumental in licensing products, raising capital from venture and corporate partners, and was a member of the executive teams that sold PathoGenesis to Chiron Corporation (now Novartis) and Corus Pharma to Gilead Sciences, Inc.
Dinu is a Fellow of the Institute of Chartered Accountants of England and Wales. He has a Masters in Management (MBA) from the J. L. Kellogg School of Business at Northwestern University, Evanston, Illinois. "Dinu brings
an outstanding record of commercial accomplishment in the pharmaceutical industry,
especially in his involvement in the successful commercialization of several
major products,"said Jeff McKelvy. "In addition, his depth of senior
management experience will help enable Avera's growth as a specialty pharmaceutical
company. We will work as a team in identification, development and commercialization
of drug candidates, in order to provide a good return to Avera's investors." Avera
Pharmaceuticals, Inc. Home
| Company Profile | Strategy
| Therapeutic Interests | Product
Pipeline | Business Development | Contact
Us ©
2002-2006 Avera Pharmaceuticals, Inc.
Avera Pharmaceuticals, Inc. (San Diego, CA) is a private, emerging pharmaceutical
company focused on the development and commercialization of novel compounds
in the neuroscience therapeutics arena. The Company's mission is to identify
opportunities for therapeutic advances in the treatment of neurologic and
psychiatric disorders, and to in-license and develop compounds that can meet
these needs. Additional information on the Company can be found at www.averapharm.com.